 |
January 18, 2011
Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor ...
|
 |
January 18, 2011
The combination of pertuzumab and trastuzumab had superior antitumor activity in women with early HER2-positive breast cancer, according to Phase II study results of the NeoSphere neoadjuvant ...
|
 |
January 18, 2011
Researchers presented Phase III efficacy data from the GeparQuinto study, a head-to-head comparison of neoadjuvant lapatinib and trastuzumab in combination with chemotherapy for patients with ...
|
 |
January 14, 2011
Professor John Heath discusses the data he presented at NCRI 2010 on the use of computer science and mathematics to model cancer pathways. Recent advances in the understanding of cancer have ...
|
 |
January 14, 2011
Prof Robert Weinberg explains what he presented at NCRI 2010 regarding the mechanisms of cancer cells disseminate within the body and the formation of metastases in distant tissues. Although this ...
|
 |
January 14, 2011
Prof Mary Gospodarowicz, president-elect of the Union for International Cancer Control (UICC), tells ecancer.tv how she hopes to take the organisation forward during her presidency. One of the ...
|
 |
January 13, 2011
Prof Gareth Morgan, Dr Faith Davies and Eric Lowe, talking at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, discuss how the data presented at the ...
|
 |
January 11, 2011
Prof Jonathan Ledermann speaks about the change in opinion towards the retreatment of patients with ovarian cancer. Recent studies have shown that the addition of trabectedin to pegylated ...
|
 |
January 11, 2011
Prof Malcolm Mason discusses the results of an intergroup study - carried out by the UK Medical Research Council (MRC), the National Cancer Institute of Canada (NCIC) and the Southwest Oncology ...
|
 |
January 11, 2011
Prof Alastair Thompson speaks to ecancer.tv a meeting on breast cancer at NCRI 2010. This meeting will look at the role of pathologists, basic scientists, clinicians and surgeons in a truly ...
|
 |
January 11, 2011
Derek Stewart, a former cancer patient, speaks about his work with the Consumer Liason Group providing a patient perspective for cancer research groups and cancer services. This group allows ...
|
 |
January 11, 2011
Prof Gerard Graham talks about the influence of chemokines on the behaviours of cancer cells. Chemokines regulate the movement of blood within the body, but it has been shown that tumour cells ...
|
 |
January 11, 2011
Prof Pamela Rabbitts talks about the Leeds Institute of Molecular Medicine and the work she has been doing on lung cancer and head and neck cancer. These two cancers show a number of similarities ...
|
 |
January 11, 2011
Dr Herve Avet-Loiseau, presenting at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, talks about the use of genomic testing to predict survival rates ...
|
 |
January 11, 2011
Dr Perkins, talking at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics discusses the work of the Multiple Myeloma Research Foundation (MMRF), whose ...
|
 |
January 11, 2011
Dr Lonial, presenting at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, talks about novel clinical trials designs particularly for melanoma. He ...
|
 |
January 11, 2011
The Co-Chairs (Dr Ken Anderson, Dr Jesus San Miguel, Dr Nikhil Munshi, Dr Keith Stewart) of the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics discuss ...
|
 |
January 11, 2011
Dr Fonseca, talking at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, discusses the occurrence of hypomethylation in myeloma and genomic prognostic ...
|
 |
January 11, 2011
Dr Chapman, speaking at the IV International Workshop on Myeloma Genetics, Pharmacogenomics & Novel Therapeutics, discusses the findings of a large genome sequencing project and the future ...
|
 |
December 28, 2010
Dr Paul Lorigan explains what the construction of the new patient treatment centre at The Christie NHS foundation Trust will mean to clinicians. The new facilities will reduce waiting times, ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|